Return to Article Details
IN VITRO PREDICTION OF DRUG RELEASE PROFILE OF RIFAMPICIN IN CROHN’S DISEASE AND CHOLESTASIS DISEASE CONDITIONS USING BIOPHARMACEUTICAL TOOLS AND BIORELEVANT MEDIA
Download
Download PDF